首页> 外文OA文献 >Survival improvement of secondary acute myeloid leukemia over time: experience from 962 patients included in 13 EORTC-Gimema-HOVON leukemia group trials

【2h】

Survival improvement of secondary acute myeloid leukemia over time: experience from 962 patients included in 13 EORTC-Gimema-HOVON leukemia group trials

机译：继发性急性髓细胞性白血病随时间的生存改善：13例EORTC-Gimema-HOVON白血病组试验中包括962例患者的经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Peer reviewed

机译：同行评审

著录项

作者
RAMADAN, Safaa M.; SUCIU, Stefan; STEVENS-KROEF, Marian J.P.L.; WILLEMZE, Roelof; AMADORI, Sergio; DE WITTE, Theo; LOWENBERG, Bob; MUUS, Petra; LABAR, Boris; MEERT, Liv; DE SCHAETZEN, Gaetan; MELONI, Giovanna; LEONE, Giuseppe; VIGNETTI, Marco; MANDELLI, Franco; BARON, Frédéric; MARIE, Jean-Pierre;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old. [J] . Parmar S, Rundhaugen LM, Boehlke L, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2004,第9期

机译：三氧化二砷在复发和难治性急性髓细胞性白血病，继发性白血病和/或至少65岁的新诊断患者中进行的II期临床试验。
2. Response Rate, Event-Free Survival (EFS), and Overall Survival (OS) in Newly-Diagnosed Acute Myeloid Leukemia (AML): US Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses [J] . Norsworthy Kelly J., Gao Xin, Ko Chia-Wen, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：新诊断急性髓性白血病（AML）中的反应率，无事故存活（EFS）和整体存活（OS）：美国食品和药物管理局（FDA）试验水平和患者水平分析
3. Event-Free Survival As a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level Analysis of Multiple Randomized Trials (Alliance A151614) [J] . Yin Jun, Uy Geoffrey L., Laplant Betsy, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：作为先前未经处理的急性髓性白血病的整体存活的替代生存的无事项生存：多次随机试验的个体患者水平分析（联盟A151614）
4. K-Means Clustering on 3^rd order polynomial based normalization of Acute Myeloid Leukemia (AML) and Acute Lymphocyte Leukemia (ALL) [C] . Mehdi A.M., Sehgal M.S., Zayegh A., Electrical Engineering, 2009. ICEE '09 . 2009

机译：基于3 ^{rd 多项式的K均值聚类基于急性髓细胞白血病（AML）和急性淋巴细胞白血病（ALL）的归一化}
5. Loss of Egr1 plays a role in murine leukemogenesis and may play a role in the development of acute myeloid leukemia and therapy-related acute myeloid leukemia. [D] . Joslin, John M. 2006

机译：Egr1的丢失在小鼠白血病的发生中起作用，并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
6. Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials [O] . Safaa M. Ramadan, Stefan Suciu, Marian J. P. L. Stevens-Kroef, 2020

机译：960 S-AML患者的存活改善包括在13个Eortc-Gimema-Hovon试验中
7. Survival Improvement Of Secondary Acute Myeloid Leukemia Over Time: Experience From 962 Patients Included In 13 EORTC-Gimema-HOVON Leukemia Group Trials [O] . Safaa M. Ramadan, Stefan Suciu, Marian J.P.L. Stevens-Kroef, 2013

机译：继发性急性髓性白血病的生存改善：962例患者中含有13名Eortc-Gimema-Hovon白血病组试验的经验

Survival improvement of secondary acute myeloid leukemia over time: experience from 962 patients included in 13 EORTC-Gimema-HOVON leukemia group trials

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅